Skip to main content
logo
Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
12.02
+0.07 (0.60%)
Apr 13, 2026, 11:20 AM EDT - Market open

COEP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
758212283094
Market Cap Growth
179.15%603.61%-57.98%-7.56%-68.04%191.32%
Enterprise Value
68.2976.312.9527.4228.1995.64
Last Close Price
12.0214.255.5015.6830.63200.00
PE Ratio
--5.07-0.99-0.95-11.65-8.13
PS Ratio
54.5660.08---1250.00
PB Ratio
5.066.043.4434.036.7339.88
P/TBV Ratio
3.754.453.1324.748.8446.43
P/FCF Ratio
--9.52-1.75-3.83-7.73-20.88
P/OCF Ratio
--9.52-1.75-3.83-7.73-20.88
EV/Sales Ratio
50.1055.98---1275.17
EV/EBITDA Ratio
--6.45-1.44-1.34-0.85-7.03
EV/EBIT Ratio
--5.85-1.29-1.28-0.82-6.81
EV/FCF Ratio
--8.87-1.95-3.79-7.27-21.30
Debt / Equity Ratio
0.000.00-0.011.460.451.73
Debt / EBITDA Ratio
-0.02-0.02-0.15-0.06-0.06-0.30
Debt / FCF Ratio
-0.03-0.03-0.21-0.17-0.53-0.91
Net Debt / Equity Ratio
-0.45-0.450.26-0.30-0.390.81
Net Debt / EBITDA Ratio
0.520.52-0.100.010.05-0.14
Net Debt / FCF Ratio
0.710.71-0.130.030.45-0.42
Asset Turnover
0.110.110000.00
Quick Ratio
7.587.580.210.501.750.79
Current Ratio
8.778.770.420.591.810.79
Return on Equity (ROE)
11.57%11.57%22.13%-807.49%-1104.48%-47.94%
Return on Assets (ROA)
-104.09%-104.09%-149.18%-344.22%-465.85%-33.65%
Return on Invested Capital (ROIC)
-143.50%-143.50%-211.63%-864.89%-844.74%-35.09%
Return on Capital Employed (ROCE)
-120.12%-120.12%-251.85%-586.75%-701.91%-34.81%
Earnings Yield
-16.02%-19.72%-101.09%-105.61%-8.59%-12.30%
FCF Yield
-11.57%-10.51%-57.13%-26.14%-12.93%-4.79%
Buyback Yield / Dilution
-120.03%-120.03%-49.84%0.00%-135.37%0.00%
Total Shareholder Return
-120.03%-120.03%-49.84%0.00%-135.37%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q